Evaluating Treatment Options for R/R Patients

September 5, 2018 10:00 am to 11:00 am
Header image
Evaluating Treatment Options for Relapsed/Refractory Patients

Date / Time



Join us for a FREE webinar designed to meet the educational

needs of multiple myeloma patients and their caregivers.

Though it is treatable, multiple myeloma remains incurable. Patients inevitably experience relapse or develop resistance to initial drug treatment. Over the past decade, these patients have benefited from the availability of an increasing number of novel agents, such as immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies. These agents have provided meaningful benefits for patients—including improved survival rates. Many more novel agents are currently being studied in clinical trials. In this webinar we review all the treatments currently available to patients with relapsed/refractory myeloma and discuss the potential of the drugs that are still under investigation and may soon be available.

There is no fee for participating in this webinar. To register, add this event to your cart and complete the required information on the checkout page.


If you are unable to register online or do not receive a confirmation email after registering (don't forget to check your spam folder), please contact our Registration Desk at 866-872-5840 (international callers please dial 617-502-2061). You can also contact us by ✉ email




Ajai Chari, MD
  • Icahn School of Medicine at Mount Sinai



Shaji K. Kumar, MD
  • Mayo Clinic




*Before you join us for the webinar(s), please provide us your responses to the following items.

*How much do you agree with the following statements?

(1 = Strongly disagree; 5 = Strongly agree)